share_log

Mateon Therapeutics Inc | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Nov 19, 2019 03:08
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.